ID Epi Seminar Series Videos


ID Epi Seminar Series 2019

 

February 7: Evolutionary constraints in influenza and their consequences for viral cooperation and conflict. Katia Koelle, PhD, Assistant Professor, Department of Biology, Emory University

February 14: Infectious disease surveillance using routine laboratory data: Building a novel platform for research on South Africa’s HIV and TB epidemics. Jacob Bor, SD, Assistant Professor, Departments of Global Health and Epidemiology, Boston University School of Public Health

February 21: Influenza vaccine research in the international setting: Trials, tribulations and lessons learned. Kathleen Neuzil, MD, MPH, FIDSA, FACP, Director, Center for Vaccine Development and Global Health, Director, Division of Geographic Medicine, Professor, Medicine and Pediatrics, University of Maryland School of Medicine

February 28:
Will original antigenic sin hinder the generation of a “universal” influenza vaccine? Rustom Antia, PhD, Professor, Department of Biology, Emory University

March 7: Influenza virus evolution, getting personal. Adam Lauring, MD, PhD, Associate Professor, Division of Infectious Diseases, Department of Microbiology & Immunology, University of Michigan

March 14: Gut microbiome dynamics during bone marrow transplantation: Revelations for the rest of us. Ying Taur, MD, MPH, Assistant Professor, Infectious Diseases, Memorial Sloan Kettering Cancer Center, Department of Medicine, Infectious Diseases Service



ID Epi Seminar Series 2018

 

May 10, 2018: Surveilling the gut bacterial pathogen landscape: Insights into multi-drug resistance. Anne-Catrin Uhlemann, MD, PhD, Florence Irving Assistant Professor of Medicine, Division of Infectious Diseases, College of Physicians and Surgeons at Columbia University

May 3, 2018: Building a better public private partnership for biosecurity: lessons from the coalition for epidemic preparedness innovations. Kendall Hoyt, PhD, Assistant Professor, Geisel School of Medicine, Dartmouth University

April 26, 2018: Immune driven pathogen evolution. Sunetra Gupta, PhD, Professor of Theoretical Epidemiology, Department of Zoology, University of Oxford

March 29, 2018:  Why has dengue resurged, why does malaria persist, and can these diseases be controlled by CRISPR-based gene drive and other novel tools? John Marshall, PhD, Assistant Professor in Residence, Biostatistics and Epidemiology, University of California, Berkeley, School of Public Health

March 22, 2018: Friend or Foe?: Immune responses to dengue and Zika Viruses. Eva Harris, PhD, Professor, Division of Infectious Diseases and Vaccinology, and Director of the Center for Global Public Health, University of California, Berkeley, School of Public Health

March 8, 2018: What is required to end AIDS as a public health threat by 2030? John Stover, Vice President and founder, Avenir Health

March 1, 2018: On the predictability of infectious disease outbreaks. Samuel Scarpino, PhD, Assistant Professor of Marine & Environmental Sciences and Physics, Northeastern University

February 22, 2018:  The incidence, etiology, and clinical sequelae of diarrheal diseases in African children before and after rotavirus vaccine introduction. Karen Kotloff, MD, Head of the Division of Infectious Disease and Tropical Pediatrics, and Associate Director of Clinical Studies at the Center for Vaccine Development, University of Maryland School of Medicine

February 15, 2018: Why biofilm growth can generate fundamentally different dynamics and mechanisms of antimicrobial resistance. Vaughn Cooper, PhD, Associate Professor, Department of Microbiology and Molecular Genetics, University of Pittsburgh